Court, J. M., Dunlop, M. E., and Boulton, T. J. C. (1974). Archives of Disease in Childhood, 49, 63. Effect of ephedrine in ketotic hypoglycaemia. The effect of oral ephedrine administration on a child with ketotic hypoglycaemia who had not responded to dietary measures alone was studied. After ephedrine administration, the hypoglycaemia developing after ketogenic stress was less profound and was substantially delayed. The impaired glycaemic response to glucagon during hypoglycaemia, characteristic of ketotic hypoglycaemia, was not altered.
The clinical features and diagnostic criteria of ketotic hypoglycaemia have been well documented (Colle and Ulstrom, 1964) , but the pathophysiology and an effective therapy are still not established.
Several workers reported a deficiency in epinephrine response to ketogenic stress in this condition (Koffler, Schubert, and Hug, 1971) . On the basis cf this observation it has been suggested that ephedrine administration may prevent hypoglycaemia induced by fasting or ketosis (Koffler et al., 1971) . These authors reported, however, that they administered ephedrine to 3 patients without success. Rosenbloom and Tiwary (1972) reported that ephedrine sulphate improved tolerance to fasting and restored the glycaemic response to glucagon in the fasting state in 2 children they studied. In one of these children, hypoglycaemic episodes ceased during 22 months of ephedrine administration.
In view of these conflicting experiences, and the failure of dietary measures alone to prevent hypoglycaemia in some children, we have studied a child with ketotic hypoglycaemia both before and after ephedrine therapy. We because of maternal pre-eclampsia. Birthweight was 1 * 4 kg, and her condition was satisfactory until the 4th day of life when some twitching was observed. This ceased on administration of phenobarbitone. She developed normally until the age of 15 months when she had a grand mal convulsion. Another seizure occurred at 33 months associated with an upper respiratory infection, when she was found to have ketonuria and a plasma glucose value of 14 mg/100 ml. Intravenous dextrose promptly terminated the convulsion, and interval electroencephalogram was normal. Her mother was asked to test the urine regularly for the presence of ketones and was given dietary advice. Despite this, the child had recurrent seizures, all before breakfast and always associated with ketonuria. No improvement was noted with the administration of prednisolone and she was therefore referred for study.
Investigations included a 5-hour oral glucose tolerance test and a ketogenic stress test. She developed hypoglycaemia during this latter test, and was found to be unresponsive to intravenous glucagon while hypoglycaemic.
After 2 weeks at home on a normal diet she was readmitted to hospital and given ephedrine sulphate 5 mg 6-hourly orally, continuing her normal diet. After 2 days a further ketogenic stress test was given under the same conditions as the previous test, but continuing ephedrine administration. Her response to intravenous glucagon was again tested when she became hypoglycaemic. On neither occasion while the child was hypoglycaemic did she convulse; she became drowsy but remained responsive throughout the test. (1965) .
Methods
Results
The oral glucose tolerance test showed a fasting plasma glucose value of 70 mg/100 ml rising to 140 mg/100 ml at 60 minutes. Values of 120, 99, 65, and 57 mg/100 ml were recorded at 2, 3, 4, and 5 hours, respectively. Insulin response to oral glucose was low, with a fasting plasma insulin of 10 FtU/ml and peak response at 1 hour of 30 ,tU/ml, and values of 30, 10, 4, and 4 ,uU/ml at 2, 3, 4, and 5 hours, respectively.
Results of the response to ketogenic stress, made before and during ephedrine administration, together with response to intravenous glucagon during hypoglycaemia, are set out in the Table. The Fig. shows the relation of onset of hypoglycaemia to development of ketonuria after starting the ketogenic diet. The results of the tests made during ephedrine administration show a delay in the development of hypoglycaemia after appearance of ketonuria, but no alteration in the lack of response to intravenous glucagon when hypoglycaemia eventually occurred. No alteration of insulin or FFA values was observed during ephedrine administration, and ephedrine was not associated with a delay in appearance of ketonuria.
Discussion
Our results do not support the report of Rosenbloom and Tiwary (1972) that ephedrine administration restores responsiveness to glucagon in ketotic hypoglycaemia. Their study, however, was inconclusive, as conditions under which the glucagon test was performed after treatment differed from those obtained before ephedrine administration. During the post-ephedrine test neither child was hypoglycaemic, and it was not recorded whether they had ketonuria. Glycaemic response to glucagon is only impaired in the ketotic hypoglycaemic state (Colle and Ulstrom, 1964) and is normal after short periods of fasting up to 12 hours (Pagliara et al., 1972 In our study, ephedrine administration did, however, appear to influence post-ketotic hypoglycaemia, both in degree and in the time it took to develop. The mechanism whereby ephedrine administration may favourably influence glucose homoeostasis in this condition remains speculative. Our results are compatible with the proposition that children with ketotic hypoglycaemia have impaired gluconeogenesis (Colle and Ulstrom, 1964) , and Pagliara et al. (1972) have suggested that this may be due to diminished availability of amino acid substrates. They showed low levels of plasma alanine in children with ketotic hypoglycaemia. Ephedrine is a sympathomimetic amine with an epinephrine-like effect, and leads also to release of norepinephrine from adrenergic nerve endings (Chidsey, Harrison, and Braunwald, 1962) . Epinepbrine leads to increased glycogenolysis by activation of hepatic phosphorylase (Sutherland and Rall, 1960) and decreased peripheral utilization of glucose (Drury and Wick, 1958, Dickman, Wiest, and Eik-Nes, 1958) .
Thus, while adequate glycogen stores exist, ephedrine may help maintain glucose homoeostasis under conditions of stress. When glycogen stores are depleted in the fasting ketotic state and glucose levels are not sustained by gluconeogenesis, ephedrine cannot be expected to prevent hypoglycaemia nor restore responsiveness to glucagon.
Levels of plasma FFA and insulin did not appear to be influenced by ephedrine administration. We recorded relatively low values of plasma insulin as reported by Senior and Loridan (1969) .
Dietary advice to the mother and instruction to give additional sugar when her child has ketonuria remain the basis for management of ketotic hypoglycaemia. If this fails to prevent episodes of hypoglycaemia however, oral ephedrine administration may have therapeutic value.
